Cheil Bio Co

Cheil Bio Co EBITDA per Share

Delisted·Feb 25, 2026

The EBITDA per Share of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -35.63 KRW. In the previous year, EBITDA per Share was -71.15 KRW — a change of -49.92% (higher).

EBITDA per Share

-35.63KRW

YoY

-49.92%

Last updated:

EBITDA per Share of Cheil Bio Co is 2024 -35.63 KRW. EBITDA per Share of Cheil Bio Co was 2023 -71.15 KRW. It decreases by -49.92% higher compared to the previous year.

The Cheil Bio Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
87.76 KRW
Jan 1, 2018
113.00 KRW
Jan 1, 2019
49.17 KRW
Jan 1, 2020
-13.04 KRW
Jan 1, 2021
-59.44 KRW
Jan 1, 2022
-54.42 KRW
Jan 1, 2023
-71.15 KRW
Jan 1, 2024
-35.63 KRW
The Cheil Bio Co EBITDA per Share history
YEAREBITDA per ShareYoY
-35.63KRW-49.92%
-71.15KRW+30.74%
-54.42KRW-8.44%
-59.44KRW+355.72%
-13.04KRW-126.53%
49.17KRW-56.49%
113.00KRW+28.75%
87.76KRW+168.16%
32.73KRW-21.23%
41.55KRW+4.73%
39.67KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

EBITDA per Share of Cheil Bio Co is -35.63 KRW in 2024.

EBITDA per Share of Cheil Bio Co changed from -71.15 KRW to -35.63 KRW, representing a -49.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cheil Bio Co

All Key Metrics — Cheil Bio Co